Updates Abound in Hyperkalemia Management

Slides:

Advertisements

Similar presentations

The Patient Experience With Systemic Lupus Erythematosus

Advertisements

The Latest Lipid Guidelines:

Prior Trials of RAAS Inhibitors

Volume 67, Pages S1-S7 (June 2005)

Silent No More:.

Talking to Patients About HCV Treatment

Emerging Concepts in Heart Failure

How the Latest Data in MDD Can Guide Treatment Decisions:

Current State of Hyperkalemia Management

Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,

Advancing Management of Anemia With the Latest Data From ERA-EDTA 2018

Starting Strong: Initial Evaluation of the Patient With HCV

New and Emerging Management Options for Anemia in CKD

PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.

Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.

New Therapies for Hyperkalemia Across the Continuum of Care

Expert Perspectives on Clinically Challenging Cases in Narcolepsy

At The Cutting Edge of Developments in the Management of Hyperkalemia

Unmet Needs in the Secondary Prevention in ACS

PCP Perspectives Clinical Considerations in Hyperkalemia

Advances in Dry Eye.

Statins and the Elderly Patient

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Management of perioperative hypertension

Iron Deficiency Anemia

Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes

Time to Take Gout Seriously

Expert Perspectives on Hyperkalemia for the Specialist

Efficacy and Safety of Edoxaban in Patients With AF and HF

Exploring Emerging Treatments for Hyperkalemia

Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA

At The Cutting Edge of Developments in the Management of Hyperkalemia

Deborah J. Clegg, PhD, Michael Cody, MD, Biff F. Palmer, MD

Figure 2 The continuum of acute kidney injury (AKI),

EXAMINE Study: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome.

Oral Anticoagulation in AF

Advancing the Treatment of IBD With Biologics

Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin.

Iron Deficiency Anemia

Multidisciplinary Management of Hyperkalemia:

Hyperkalemia in the Hospital

Volume 88, Issue 6, Pages (December 2015)

Shifting Currents in Hyperkalemia Management 2015 in Review

Shifting Currents in Hyperkalemia Management 2015 in Review

Volume 88, Issue 2, Pages (August 2015)

Managing CKD-Associated Anemia in Challenging Patients

What You Didn't Know About AF and Renal Dysfunction

Managing Age-Related Clinical Issues in Hemophilia

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Current Controversies and Advances in Hepatorenal Syndrome

Latest Lipid Guidelines in Perspective

Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA

HARMONIZE Trial design: Patients with hyperkalemia (K ≥5.1 mEq/L) were randomized in a 1:1:1:1.7 fashion to receive sodium zirconium cyclosilicate (ZS)

Introduction. Emerging Treatments for Thrombocytopenia in Adults With CLD Requiring Elective Invasive Procedures.

Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.

Biff F. Palmer, MD American Journal of Kidney Diseases

Assessing the Burden of Hyperkalemia

Breaking Down the Data in Hyperkalemia

Volume 73, Pages S5-S17 (April 2008)

A Family Affair.

Assessing the Burden of Hyperkalemia

Lipids, the Heart, and the Kidney

Clinical Comparisons.

RAASi Enabling in the Modern Era

PCSK9 Inhibitors and Real-World Evidence

Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.

The causes and treatment of hyperkalemia across the continuum of kidney function and with kidney replacement therapies. The causes and treatment of hyperkalemia.

Potassium Situations Resolved

Presentation transcript:

Updates Abound in Hyperkalemia Management

Normal Potassium Homeostasis

Normal Kidney Potassium Handling

Causes of Hyperkalemia

Pseudohyperkalemia

Consequences of Hyperkalemia

Hyperkalemia in CKD

Prevalence of Hyperkalemia in Patients With CKD Who Are Not on Dialysis

Predisposition to Hyperkalemia

Relationship Between Potassium Level and Risk of Mortality

Mortality Rate Within 1 Day of a Hyperkalemia Event

Predictors of Hyperkalemia[a]

Stepwise Approach to Evaluating and Treating Hyperkalemia

Pathogenesis of Hyperkalemia: RAAS and Potassium Excretion

To Stop or Not to Stop RAASi

SPS

Hyperkalemia Is a Fluid Continuum of Decisions Use Clinical Experience

Considering ECG Changes When Treating Hyperkalemia

Patiromer

Long-Term Efficacy and Safety of Patiromer

ZS-9 (Sodium Zirconium Cyclosilicate)

Comparison of SPS, Patiromer, and ZS-9

ZS-9 -- Rapid Onset of Action

Take-Home Messages

Abbreviations

Abbreviations (cont)